CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 24 enrolled
Drug / intervention
Bi-hormonal (insulin and glucagon) artificial pancreasdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01161862
NCT01161862N/ACompleted
CompareCT.gov

Integration of Continuous Glucose Monitoring Into a Bi-Hormonal Closed-Loop Artificial Pancreas for Automated Management of Type 1 Diabetes

Boston University Charles River Campus·interventional·Posted Jul 14, 2010·Updated Nov 14, 2017

In Brief

A clinical study evaluating Bi-hormonal (insulin and glucagon) artificial pancreas for Diabetes Mellitus. Completed, enrolled 24 participants across 1 site.

Detailed Summary

The investigators hypothesize that our closed-loop glucose-control system can provide BG control in subjects with type 1 diabetes using the estimated BG signal from a CGM as the input signal to the controller.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus
CountriesUnited States
CollaboratorsMassachusetts General Hospital, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Juvenile Diabetes Research Foundation, The Leona M. and Harry B. Helmsley Charitable Trust

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJul 14, 2010
Enrollment StartJul 1, 2010
Primary CompletionDec 1, 2012
Study CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 16.0 years ago

Interventions

Bi-hormonal (insulin and glucagon) artificial pancreasdevice

Subjects wore a bionic pancreas consisting of a continuous glucose monitor, an insulin pump and a glucagon pump